Gross Margin
24.63%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 20.65%.Updated Sep 20, 2026Profit Margin
0.28%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Margin
4.36%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Assets (TTM)
-0.10%vs Specialty Chemicals peers Updated Sep 20, 2026Return on Equity (TTM)
-0.66%vs Specialty Chemicals peers Updated Sep 20, 2026Revenue (TTM)
2.63TKRW1.90B · vs all stocks (USD) Updated Sep 20, 2026Revenue per Share (TTM)
135.96KKRWUpdated Sep 20, 2026Quarterly Revenue Growth
24.80%vs Specialty Chemicals peers Updated Sep 20, 2026Gross Profit (TTM)
543.59BKRW392.10M · vs all stocks (USD) Updated Sep 20, 2026EBITDA (TTM)
228.57BKRW164.87M · vs all stocks (USD) Updated Sep 20, 2026Net Income (TTM)
2.44BKRW1.76M · vs all stocks (USD) Updated Sep 20, 2026Quarterly Earnings Growth (YoY)
-37.00%vs Specialty Chemicals peers Updated Sep 20, 2026Operating Cash Flow (TTM)
153.19BKRW110.50M · vs all stocks (USD) Updated Sep 20, 2026Levered Free Cash Flow (TTM)
-319.90BKRW-230.75M · vs all stocks (USD) Updated Sep 20, 2026Trailing Annual Dividend Rate
400.00KRWUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.79%Updated Sep 20, 20265-Year Average Dividend Yield
1.68%Updated Sep 20, 2026Payout Ratio
312.50%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 17.35%.Updated Sep 20, 2026Minority Interest (Equity)
881.11BKRWFY2025 · Dec 31, 2025Revenue
2.37TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
1.87TKRWFY2025 · Dec 31, 2025Gross Profit
499.11BKRWFY2025 · Dec 31, 2025Operating Income
280.04MKRW202.00K · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
16.67BKRWFY2025 · Dec 31, 2025Income Tax Expense
-10.62BKRWFY2025 · Dec 31, 2025Net Income
27.30BKRWFY2025 · Dec 31, 2025EBIT
67.10BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
201.18BKRWFY2025 · Dec 31, 2025Research & Development
118.95BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
173.46BKRWFY2025 · Dec 31, 2025Other Operating Expenses
4.34BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
25.09BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
50.43BKRWFY2025 · Dec 31, 2025EPS (Basic)
2.31KKRWFY2025 · Dec 31, 2025EPS (Diluted)
2.31KKRWFY2025 · Dec 31, 2025Basic Shares Outstanding
19.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
19.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
27.30BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
17.35BKRWFY2025 · Dec 31, 2025Operating Cash Flow
38.18BKRWFY2025 · Dec 31, 2025Free Cash Flow
-267.60BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
567.56BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
27.30BKRWFY2025 · Dec 31, 2025Stock-based Compensation
670.09MKRWFY2025 · Dec 31, 2025Other Non-cash Items
28.33BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-46.73BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
28.61BKRWFY2025 · Dec 31, 2025Capital Expenditures
-305.79BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-80.25BKRWFY2025 · Dec 31, 2025Net Acquisitions
-3.61BKRWFY2025 · Dec 31, 2025Purchase of Investments
-82.08BKRWFY2025 · Dec 31, 2025Sale of Investments
0.00KRWFY2025 · Dec 31, 2025Other Investing Activity
-213.11BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-604.59BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
1.21TKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-928.11BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-122.53BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-22.53BKRWFY2025 · Dec 31, 2025Other Financing Charges
794.70MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
138.22BKRWFY2025 · Dec 31, 2025